PIONEERING HEALTHCARE FOR THE HUMAN RACE

Learn more about our products

Latest News

13February, 2019

Mundipharma introduces new BETADINETM Cold Defence to quickly and effectively tackle common colds

New BETADINETM Cold Defence exhibits antiviral properties1,2 and found to combat symptoms and reduce duration of common cold by 2 days3,4 Millions of people all over the world will be suffering...
Read more
24thJanuary, 2019

Mundipharma introduces new BETADINETM Cold Defence to quickly and effectively tackle common colds

New BETADINETM Cold Defence exhibits antiviral properties1,2 and found to combat symptoms and reduce duration of common cold by 2 days3,4 Millions of people all over the world will be suffering...
Read more
26thNovember, 2018

Betadine Cold Defense extension agreement with Marinomed

Mundipharma set to provide innovative cold treatment for Adults and Children in new markets across the Middle East, Turkey and Africa region 16, January, Dubai: Mundipharma, the maker of the...
Read more
12thNovember, 2018

Mundipharma signs licensing agreement with Moberg Pharma to bring leading fungal nail treatment to MEA region

EmtrixTM, the leading treatment for patients suffering from nail fungus and nail psoriasis, will be licensed by Mundipharma from the Swedish pharmaceutical company and to be marketed as part of the...
Read more
20thSeptember, 2018

Mundipharma adds new range of BETADINE™ pediatric medicines to its growing children’s healthcare portfolio

Nasal and ear sprays and decongestants will be available to patients aged 6 months to 10 years across Middle East, Turkey and Africa. XX August, Dubai: Mundipharma’s commitment to tackling some...
Read more
04thMay, 2018

Mundipharma and Endoceutics to Exclusively License Intrarosa™ (Prasterone) in MEA Region

A unique non-estrogen prescription therapy, Intrarosa™, has been approved by the US Food and Drug Administration (FDA) and by the European Medical Agency (EMA), for the treatment of the most...
Read more

Products

Mundipharma actively works to ensure that its medicines are marketed responsibly and in accordance with the regulatory frameworks in each country it operates in. Mundipharma prides itself on being an ethical company, and continues to work closely with regulators, and within strict regulatory constraints, to address the unmet need of patients across the META region.

Analgesia

thumb-Analgesia-resized

Analgesia

Our largest area of expertise, this range offers oral, transdermal and parenteral delivery of analgesia for pain relief.

See More

Oncology

H3

Oncology

Our range of oncology products includes treatments for neuro-oncological and haematological malignancies.

See More

Ophthalmology

thumb-Ophthalmology-resized

Ophthalmology

Our ophthalmology portfolio consists of a range of trusted products that cover the primary treatment methods for patients with open-angle glaucoma.

See More

Respiratory

thumb-respiratory-resized

Respiratory

This range offers treatment for respiratory diseases, particularly asthma which affects millions

See More

Consumer Healthcare

consumer healthcare

Consumer Healthcare

The trusted brand for treating small wounds and grazes, sore throats, feminine infections.

See More
mundipharma-video-image



icon-document

MEDIA CENTRE

Learn more about our recent media activities at the Mundipharma media centre.

Find out more

Mundipharma_homepage_addedHCPPortal-icon

Health Professionals Portal

Read the latest news and join our forum discussions.

Coming soon.

Learn more about us through the following links:

↓
WordPress Video Lightbox Plugin